Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
India · Delayed Price · Currency is INR 138.49
+6.59 (5.00%)
Jun 1, 2026, 1:52 PM IST
Bafna Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 111 | 41.53 | 73.48 | 113.38 | 52.16 |
Depreciation & Amortization | 60.73 | 48.9 | 49.95 | 53.34 | 54.93 |
Loss (Gain) From Sale of Assets | -0.01 | 0.74 | -0.66 | -1.96 | - |
Asset Writedown & Restructuring Costs | 3.1 | - | - | - | - |
Provision & Write-off of Bad Debts | -1.18 | -2.83 | 6 | 6.73 | - |
Other Operating Activities | 36.13 | 57.53 | 18.87 | 22.24 | -1.86 |
Change in Accounts Receivable | -36.37 | 55.04 | -48.46 | -270.42 | -61.12 |
Change in Inventory | -8.17 | 11.8 | -74.23 | -19.39 | -48.37 |
Change in Accounts Payable | 3.41 | -44.77 | 69.62 | 160.56 | 122.18 |
Change in Other Net Operating Assets | -14.91 | 53.42 | 0.28 | -14.95 | -20.64 |
Operating Cash Flow | 153.71 | 221.36 | 94.85 | 49.53 | 97.28 |
Operating Cash Flow Growth | -30.56% | 133.38% | 91.52% | -49.09% | - |
Capital Expenditures | -249.03 | -218.6 | -155.78 | -67.19 | -75.41 |
Sale of Property, Plant & Equipment | 0.2 | 0.59 | 1.71 | 1.96 | - |
Sale (Purchase) of Intangibles | - | - | -2.7 | -15 | - |
Investment in Securities | - | -0.01 | - | - | - |
Other Investing Activities | 24.82 | 6.39 | 6.24 | 5.29 | 9.97 |
Investing Cash Flow | -224.01 | -211.63 | -150.54 | -74.93 | -65.44 |
Long-Term Debt Issued | 92.35 | 38.09 | 14.65 | 118.65 | - |
Total Debt Issued | 92.35 | 38.09 | 14.65 | 118.65 | - |
Long-Term Debt Repaid | - | - | - | - | -47.27 |
Total Debt Repaid | - | - | - | - | -47.27 |
Net Debt Issued (Repaid) | 92.35 | 38.09 | 14.65 | 118.65 | -47.27 |
Other Financing Activities | -36.12 | -27.46 | -23.11 | -16.87 | -0.88 |
Financing Cash Flow | 56.22 | 10.64 | -8.45 | 101.77 | -48.15 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - |
Net Cash Flow | -14.08 | 20.37 | -64.14 | 76.36 | -16.31 |
Free Cash Flow | -95.32 | 2.76 | -60.93 | -17.66 | 21.87 |
Free Cash Flow Margin | -6.13% | 0.19% | -4.00% | -1.53% | 2.57% |
Free Cash Flow Per Share | -4.03 | 0.12 | -2.58 | -0.75 | 0.93 |
Cash Interest Paid | - | 27.46 | 23.11 | 16.87 | 0.88 |
Cash Income Tax Paid | - | -3.5 | 1.74 | 1.28 | 1.7 |
Levered Free Cash Flow | -169.98 | -74.58 | -124.36 | -97.3 | 13.94 |
Unlevered Free Cash Flow | -147.1 | -58.57 | -112.25 | -86.07 | 17.22 |
Change in Working Capital | -56.05 | 75.49 | -52.8 | -144.2 | -7.95 |